Improve Cancer-related Cognitive Impairment
Using a Novel Mobile Cognitive Training Application to Improve Cancer-related Cognitive Impairment in Gynecologic Oncology Patients
University of Alabama at Birmingham
64 participants
Sep 1, 2024
INTERVENTIONAL
Conditions
Summary
Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients undergoing chemotherapy, radiation, and/or hormonal treatments. This application focuses on evaluating if using a cognitive mobile training application can decrease the impact of CRCI in gynecologic oncology patients through a multidisciplinary approach with patients undergoing assessments by our neurocognitive team.
Eligibility
Inclusion Criteria3
- newly diagnosed gynecologic malignancy (uterine, cervical, ovarian, primary peritoneal, vulvar, or vaginal) and undergoing chemotherapy
- own a smartphone or tablet with ability to download cognitive training application
- and age \>21 years old
Exclusion Criteria3
- medical diagnosis of dementia
- significant underlying mental diagnoses for which they are on more than 1 medication for (patients with depression or anxiety on single-agent therapy will be able to participate
- age \<21
Interventions
Patients will participate with a cognitive training application and undergo neurocognitive testing during and after chemotherapy.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05864274